MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 May 2023 Evaluate
The revenue zoomed 16.46% to Rs. 2099.01 millions for the quarter ended March 2023 as compared to Rs. 1802.34 millions during the corresponding quarter last year.The Total revenue for the quarter ended March 2023 of  Rs. 659.31  millions  grew by 47332.37% from Rs. 1.39 millions.OP of the company witnessed a marginal growth to 414.17 millions from 312.25 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2099.01 1802.34 16.46 6658.98 5569.74 19.56 6658.98 5569.74 19.56
Other Income 17.29 17.47 -1.03 194.31 90.03 115.83 194.31 90.03 115.83
PBIDT 414.17 312.25 32.64 1030.49 662.62 55.52 1030.49 662.62 55.52
Interest 74.84 44.59 67.84 322.26 320.12 0.67 322.26 320.12 0.67
PBDT 731.43 267.66 173.27 1100.33 342.50 221.26 1100.33 342.50 221.26
Depreciation 72.12 266.27 -72.91 547.86 870.21 -37.04 547.86 870.21 -37.04
PBT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 19.73 17.32 13.89 15.48 11.90 30.08 15.48 11.90 30.08
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..